de la Morena-Barrio ME, Suchon P, Jacobsen EM, et al. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays. Blood. 2022;140(2):140-151.

doi:10.1182/blood.2024025851

Skip Nav Destination

ERRATUM| August 15, 2024

de la Morena-Barrio ME, Suchon P, Jacobsen EM, et al. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays. Blood. 2022;140(2):140-151.

Blood (2024) 144 (7): 795.

https://doi.org/10.1182/blood.2024025851

In “Acknowledgments” on page 149, “This work was supported by PI18/00598 & PI21/00174 (ISCIII & FEDER)” should read “This work was supported by grants PI18/00598 (ISCIII and FEDER) and PI21/00174 (ISCIII, cofunded by the European Union).”

© 2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

2024

de la Morena-Barrio ME, Suchon P, Jacobsen EM, et al. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays. Blood. 2022;140(2):140-151.

Contents

Data & Figures

Supplemental data

References

Cited By

Email alerts

ASH Publications

American Society of Hematology

de la Morena-Barrio ME, Suchon P, Jacobsen EM, et al. Two SERPINC1 variants affecting N-glycosylation of Asn224 cause severe thrombophilia not detected by functional assays. Blood. 2022;140(2):140-151.

Contents

Data & Figures

Supplemental data

References

Related

Related

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only